About Thomas Chen
Thomas Chen is CEO and director at Neonc Technologies.
Form D filings also name Thomas Chen as a director at Cognos Therapeutics.
Thomas Chen reports to the SEC as a director, officer or major shareholder of 1 public company.
Thomas Chen first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Chen in the role, so the role may have started earlier or lasted longer.
Cognos Therapeutics Inc
Director
2015 – 2026 · Inglewood, CA
Develops implantable drug delivery pumps for people with neurological diseases and cancer.
Key Colleagues at Startups
The people Thomas Chen works with at each company, as listed on that company's latest Form D.
Cognos Therapeutics Inc · Form D, Jul 2, 2026
Eli Gang
Director
Frank Adell
Chief Executive Officer & Board Member
Neonc Technologies Holdings, Inc. · Form D, Jun 25, 2026
YE
Yousha Neman-Ebrahim
Executive officer
BM
Bader Al Monawer
Director
JD
Jim Delshad
Director
AH
Amir Heshmatpour
CEO and director
VM
Victoria Medvec
Director
SG
Steven Giannotta
Director
KG
Keithly Garnett
Executive officer
DC
David Choi
Executive officer
MC
Ming-Fu Chiang
Director